ANIP Dividend: ANI Pharmaceuticals Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

ANIP Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	826	614	486	316	216	208
Revenue Growth (YoY)	19%	26%	54%	46%	4%	1%
Cost of Revenue	321	250	181	138	100	87
Gross Profit	505	364	305	177	115	121
Selling, General & Admin	304	249	161	124	84	65
Research & Development	56	44	34	22	11	16
Operating Expenses	424	361	257	207	143	125
Other Non Operating Income (Expenses)	0	-4	0	0	-4	0
Pretax Income	50	-22	19	-62	-56	-26
Income Tax Expense	9	-3	1	-14	-13	-3
Net Income	34	-20	15	-49	-42	-22
Net Income Growth	386%	-233%	-131%	17%	91%	-467%
Shares Outstanding (Diluted)	21.09	19.31	18.19	16.3	12.6	12
Shares Change (YoY)	9%	6%	12%	28.99%	5%	0%
EPS (Diluted)	1.63	-1.04	0.85	-3.05	-3.4	-1.88
EPS Growth	317%	-222%	-128%	-10%	81%	-476%
Free Cash Flow	155	47	110	-40	0	9
Free Cash Flow Per Share	7.34	2.43	6.04	-2.45	0	0.75
Gross Margin	61.13%	59.28%	62.75%	56.01%	53.24%	58.17%
Operating Margin	9.68%	0.32%	9.87%	-9.17%	-12.5%	-1.92%
Profit Margin	4.11%	-3.25%	3.08%	-15.5%	-19.44%	-10.57%
Free Cash Flow Margin	18.76%	7.65%	22.63%	-12.65%	0%	4.32%
EBITDA	171	69	107	28	20	40
EBITDA Margin	20.7%	11.23%	22.01%	8.86%	9.25%	19.23%
D&A For EBITDA	91	67	59	57	47	44
EBIT	80	2	48	-29	-27	-4
EBIT Margin	9.68%	0.32%	9.87%	-9.17%	-12.5%	-1.92%
Effective Tax Rate	18%	13.63%	5.26%	22.58%	23.21%	11.53%